Bio-Path Holdings Announces Executive and Director Changes
Ticker: BPTH · Form: 8-K · Filed: Nov 14, 2025 · CIK: 1133818
| Field | Detail |
|---|---|
| Company | Bio-Path Holdings, Inc. (BPTH) |
| Form Type | 8-K |
| Filed Date | Nov 14, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, corporate-governance
Related Tickers: BPTH
TL;DR
Bio-Path Holdings shakes up leadership and compensation - new directors in, some execs out.
AI Summary
Bio-Path Holdings, Inc. announced on November 4, 2025, changes in its executive and director positions. The company filed an 8-K report detailing the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for its officers.
Why It Matters
Changes in leadership and compensation can signal shifts in company strategy or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in executive and director roles can indicate internal restructuring or strategic shifts, which may carry inherent risks.
Key Players & Entities
- BIO-PATH HOLDINGS, INC. (company) — Registrant
- November 4, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-36333 (commission_file_number) — SEC File Number
- 87-0652870 (ein) — EIN
FAQ
What specific roles have been affected by the changes in directors or officers?
The filing indicates the departure of certain officers and directors, the election of new directors, and changes to compensatory arrangements for certain officers, but does not specify the exact roles affected in this summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on November 4, 2025.
What is the exact name of the registrant?
The exact name of the registrant is BIO-PATH HOLDINGS, INC.
In which state is Bio-Path Holdings, Inc. incorporated?
Bio-Path Holdings, Inc. is incorporated in Delaware.
What is the SEC file number for Bio-Path Holdings, Inc.?
The SEC file number for Bio-Path Holdings, Inc. is 001-36333.
Filing Stats: 530 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2025-11-14 12:10:42
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BPTH N/A Indicate by ch
Filing Documents
- bpth_8k110425.htm (8-K) — 29KB
- 0001663577-25-000317.txt ( ) — 227KB
- bpth-20251104.xsd (EX-101.SCH) — 3KB
- bpth-20251104_def.xml (EX-101.DEF) — 25KB
- bpth-20251104_lab.xml (EX-101.LAB) — 35KB
- bpth-20251104_pre.xml (EX-101.PRE) — 24KB
- bpth_8k110425_htm.xml (XML) — 5KB
02 Departure of Directors or Principal Officers; Election
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. On November 13, 2025, the Board of the Company accepted the resignation of Douglas Morris as member of the Board of Directors which was provided electronically to us on November 4, 2025.
01 Other Events
Item 8.01 Other Events. We are currently seeking financing to support our planned turnaround of the Company which we anticipate will include updating our finance team, engaging new PCAOB auditors, hiring investment bankers to review our biotech portfolio for sale, partnerships or other, and pursuing strategic mergers and acquisitions. There can be no assurances we will be successful in raising capital or executing on our turnaround plans. If we are unable to raise capital, there is substantial doubt as to our ability to continue as a going concern and remain listed on the OTC Markets or other public trading platforms. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-PATH HOLDINGS, INC. Dated: November 14, 2025 By: /s/ Vikram Grover Vikram Grover Chief Executive Officer, Chief Financial Officer and Director 3